Skip to main content
SpringerLink
Log in

Biological Examinations

  • Chapter
Exocrine Pancreatic Cancer

  • 52 Accesses

Abstract

Biological examinations have only a relative value in the detection of carcinoma of the pancreas, as they do not completely compensate for the weakness of clinical examinations. Considering the repercussions of the tumor process on the biliary pancreatic functions (cholestasis, diabetes mellitus, pancreatic insufficiency of the exocrine functions), disturbances of the biological parameters are frequently of indirect significance. The hope placed on the assays of certain tumor markers in blood and pancreatic juice, has been disappointing in almost all cases, due to the lack of specificity among the substances studied, regardless of their frequent presence in cancer of the exocrine pancreas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Banwo O, Versey J, Hobbs JR (1974) New oncofetal antigen for human pancreas. Lancet 1: 643–645.

    Article  PubMed  CAS  Google Scholar 

  2. Barkin JS, Kaiser MH, Kaplan R, Redlhammer D, Heal A (1978) Initial levels of CEA and their rate of change in pancreatic carcinoma following surgery, chemotherapy and radiation therapy. Cancer 42: 1472–1476.

    Article  PubMed  CAS  Google Scholar 

  3. Bellart M, Vion A, Colombel JF, Cortot A, Paris JC, Montreuil J (1985) L’activité galactosyl + transférase sérique n’est pas un bon marqueur tumoral de cancer du pancréas. Gastroenterol Clin Biol 9: 205 A.

    Google Scholar 

  4. Braganza JM, Howat MT (1972) Cancer of the Pancreas. Clinics in Gastroenterology 1: 219–237.

    Google Scholar 

  5. Braganza JM, Howat MT (1980) Tumeurs du pancréas exocrine: in H. Sarles et MT Howat. Le Pancréas Exocrine, Paris 463–495.

    Google Scholar 

  6. Burton P, Evans DG, Harper AA, Howat MT, Oreesky S, Scott JE, Varley H (1960) A test of pancreatic function in man based on the analysis of duodenal contents after administration of secretin and pancreozymin. Gut 1, 111–124.

    Article  PubMed  CAS  Google Scholar 

  7. Cancer of the pancreas task force: Staging of cancer of the pancreas. Cancer 1981, 47, 1631–1637.

    Article  Google Scholar 

  8. Collure WD, Burns GP, Schenk WG (1974) Clinical, pathological and therapeutic aspects of carcinoma of the panceas. Am J Surg 1974, 128, 683–689.

    Article  PubMed  CAS  Google Scholar 

  9. Delchier JC, Soule JC (1983) BT-PABA test with plasma PABA measurements: Evaluation of sensitivity and specificity. Gut 24: 318–325.

    Article  PubMed  CAS  Google Scholar 

  10. Del Villano BC, Brennan S, Brock P, Bucher C, Liu V, McClure M, Rake B, Space S, Westrick B, Schoemaker H, Zurawski VR (1983) Radio-immunometric assay for a monoclonal antibodydefined tumor marker CA 19-9. Clin Chem 29: 549–552.

    PubMed  Google Scholar 

  11. Di Magno EP, Malagelada JR, Moertel CG, Go VLW (1977) Prospective evaluation of the pancreatic secretion of immuno-reactive carcino-embryonic antigen, enzyme and bicarbonate in patients suspected of having pancreatic cancer. Gastroenterology 73: 457–461.

    Google Scholar 

  12. Di Magno EP, Malagelada JR, Taylor WP, Go VLW (1977) A prospective comparison of current diagnostic tests in pancreatic cancer. N Engl J Med 297: 737–742.

    Article  Google Scholar 

  13. Dreiling DA (1951) Studies in pancreatic function, in the use of the secretin test in the diagnosis of tumors in and about the pancreas. Gastroenterology 18: 184–196.

    PubMed  CAS  Google Scholar 

  14. Dreiling DA, Hollander F (1948) Studies in pancreatic function, preliminary series of clinical studies with secretin test. Gastroenterology 11: 714–729.

    PubMed  CAS  Google Scholar 

  15. Dreiling DA (1970) The early diagnosis of pancreatic cancer. Scan J Gastroenterol (suppl) 6: 115–122.

    CAS  Google Scholar 

  16. Estevenson JP, Sarles M, Figarella C (1975) Lactoferrin in the duodenal juice of patients with chronic pancreatitis. Scand J Gastroent 10: 327–330.

    Google Scholar 

  17. Fedail SS, Harvey RF, Salmon PR, Brown P, Read AE (1978) Trypsin and lactoferrin levels in pure pancreatic juice in patients with pancreatic disease. Gut 20: 983–986.

    Article  Google Scholar 

  18. Fedail SS, Salmon PR, Harvey RF, Brown P, Read AE (1978) The value of pure pancreatic juice trypsin in the differential diagnosis of pancreatic disease. Gastroenterology 74: 1154.

    Google Scholar 

  19. Fitzgerald PJ, Fortner JG, Watson RC, Schwartz MK, Sherlock P, Cubilla AL, Schottenfeld D, Miller D, Winauer SJ, Lightdale CJ, Leidner SD, Nisselbaum JS, Menendez-Bodet CJ, Poleski MH (1978) The value of diagnostic aids in detecting pancreatic cancer. Cancer 41: 868–879.

    Article  PubMed  CAS  Google Scholar 

  20. Gelder FB, Reese CJ, Moossa AR, Hall T, Hunter R (1978) Purification, partial characterization, and clinical evaluation of a pancreatic oncofetal antigen. Cancer Res 38: 313–324.

    PubMed  CAS  Google Scholar 

  21. Goldrosen MH, Dashmahapatra K, Jenkins D, Howell JC, Arbuck SG, Moore MC, Douglas HO (1981) Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: Detection of specific antitumor immunity with patient’s peripheral blood cells and serum. Cancer 47: 1614–1619.

    Article  PubMed  CAS  Google Scholar 

  22. Gullick MD (1959) Carcinoma of the pancreas. Medicine 38: 47–84.

    PubMed  CAS  Google Scholar 

  23. Hobbs JR, Knapp ML, Branfoot AC (1979) Oncofetal pancreatic antigen (OPA), its frequency and localization in humans (Abstract No 1) VIIth Mtg. International Society for Oncodevelopmental Biology and Medicine. London, Sept 1979 (Abstract).

    Google Scholar 

  24. Khoo SK, Mackay IR (1973) Carcino-embryonic antigen in serum in disease of the liver and pancreas. J Clin Path 26: 470–475.

    Article  PubMed  CAS  Google Scholar 

  25. Klavins JW (1981) Tumor markers of pancreatic carcinoma. Cancer 47: 1597–1601.

    Article  PubMed  CAS  Google Scholar 

  26. Lurie BB, Loewenstein MS, Zamcheck N (1975) Elevated carcino-embryonic antigen levels and biliary tract obstruction. J Amer Med Assn 233: 326–330.

    Article  CAS  Google Scholar 

  27. Malagelada JR (1979) Pancreatic cancer. An overview of epidemiology clinical presentation and diagnosis. Mayo Clin Proc 34: 459–467.

    Google Scholar 

  28. Molnar IG, Vandevoorde JP, Gitnick GL (1976) CEA levels in fluids bathing gastro-intestinal tumors. Gastroenterology 70: 513–515.

    PubMed  CAS  Google Scholar 

  29. Moore TL, Kupchik HZ, Marcon N, Zamcheck N (1971) Carcino-embryonic antigen assay in cancer of the colon and pancreas and other digestive tract disorders. Amer J Digest Dis 16: 1–7.

    Article  CAS  Google Scholar 

  30. Moore T, Dhar P, Zamcheck N, Keeley A, Gottlieb L, Kupchik HZ (1972) Carcino-embryonic antigen (s) in liver disease. Clinical and morphological studies. Gastroenterology 63: 88–94.

    PubMed  CAS  Google Scholar 

  31. Moossa AR (1982) Pancreatic cancer: Approach to diagnosis selection for surgery and choice of operation. Cancer 50: 2689–2698.

    PubMed  CAS  Google Scholar 

  32. Moossa AR, Levin B (1981) The diagnosis of “early” pancreatic cancer: the University of Chicago experience. Cancer 47: 1688–1697.

    Article  PubMed  CAS  Google Scholar 

  33. Olsson NO, Crimet-Montange D, Martin F (1985) Valeur diagnostique d’un nouveau marquer serique des cancers digestifs humains: l’antigène carbohydrate 19.9 (CA 19-9). Comparaison avec l’antigène carcino-embryonnaire. Gastroentérol Clin Biol 9: 206–211.

    PubMed  CAS  Google Scholar 

  34. Ona FV, Zamcheck N, Dhar P, Moore T, Kupchik H (1973) Carcino-embryonic antigen (CEA) in the diagnosis of pancreatic cancer. Cancer 31: 324–327.

    Article  PubMed  CAS  Google Scholar 

  35. Pignal F, Benque A, Bouisson M, Arany Y, Ribet A (1984) Lactoferrine et cancer du pancreas. Gastroenterol Clin Biol 8: 982.

    PubMed  CAS  Google Scholar 

  36. Podolsky DK, Weiser MM, Isselbacher KJ, Cohen AM (1978) A cancer-associated galactosyltransferase isoenzyme. N Engl J Med 299: 703–705.

    Article  PubMed  CAS  Google Scholar 

  37. Podolsky DK, McPhee MS, Alpert E, Warshaw AL, Isselbacker KJ (1981) Galactosyl transferase isoenzyme II in the detection of pancreatic cancer: comparison with radiologic, endoscopic and serologic tests. N Engl J Med 304: 1313–1318.

    Article  PubMed  CAS  Google Scholar 

  38. Reber HA, Tweedie JH, Austin JL (1981) Pancreatic secretions as a clue to the presence of pancreatic cancer. Cancer 47: 1646–1651.

    Article  PubMed  CAS  Google Scholar 

  39. Ricolleau G, Kremer M, Curtet C, Fumoleau P, Douillard JY, Le Mevel B, Le Bodic L, Chatal JF (1983) Intérêt diagnostique comparé au radio-immunodosage de l’antigène carcino-embryonnaire et de l’antigène CA 19-9 isolé par un anticorps monoclonal. Gastroentérol Clin Biol 7: 25 A.

    Google Scholar 

  40. Russo AJ, Douglass HO, Leveson SH, Howell JH, Holyoke ED, Harvey SR, Chu TM, Goldrosen MH (1978) Evaluation of the micro-leukocyte adherence inhibition assay as an immunodiagnostic test for pancreatic cancer. Cancer Res 38: 2023–2026.

    PubMed  CAS  Google Scholar 

  41. Schmiegel WH, Becker WM, Arnot R, Hamann A, Sohendra N, Jessen K, Classen M, Thiele HG (1981) Pancreatic oncofetal antigen in pancreatic juice. Partial chemical characterization and diagnostic application of a pancreatic cancer associated antigen. Scand J Gastroenterol 16: 1033–1040.

    Article  PubMed  CAS  Google Scholar 

  42. Schwartz SS, Ziedler A, Moossa AR, Kuku JF, Rubenstein AM (1978) A prospective study of glucose tolerance insulin, C-Peptide, N-Glucagon responses in patients with pancreatic carcinoma. Dig Dis Sci 23: 1107–1114.

    Article  CAS  Google Scholar 

  43. Sharma MP, Gregg JA, Loewenstein MS, McCabe RP, Zamcheck N (1976) Carcinoembryonic antigen (CEA) activity in pancreatic juice of patients with pancreatic carcinoma and pancreatitis. Cancer 38: 2457–2461.

    Article  PubMed  CAS  Google Scholar 

  44. Shimano T, Loor RM, Papsidero LD, Kuriyama M, Vincent RG, Nemoto T, Holyoke ED, Berjian R, Douglass HO, Chu TM (1981) Isolation, characterization and clinical evaluation of a pancreas cancer-associated antigen. Cancer 47: 1602–1613.

    Article  PubMed  CAS  Google Scholar 

  45. Skarin AT, Delwiche R, Zamcheck N, Lokich JJ, Frei E (1974) Carcino-embryonic antigen: clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer 33: 1239–1245.

    Article  PubMed  CAS  Google Scholar 

  46. Tatsuta M, Yamamura M, Yamamoto R (1983) Significance of carcino-embryogenic antigen levels and cytology of pure pancreatic juice in diagnosis of pancreatic cancer. Cancer 52: 1880–1885.

    Article  PubMed  CAS  Google Scholar 

  47. Tatsuta M, Yamamura H, Iishi H, Ichii M, Noguchi S, Yamamodo R, Okuda S (1985) Values of CA 19-9 in the serum, pure pancreatic juice and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor. Cancer 56: 2669–2673.

    Article  PubMed  CAS  Google Scholar 

  48. Venot J, Vincent D, Clement MN, Beck C (1984) Evaluation d’un marqueur tumoral du pancréas. Resultats préliminaires. La Presse Méd 13: 440–441.

    CAS  Google Scholar 

  49. Venot J, Vincent D, Canard JM, Larnant A, Descottes B (1985) Pathologie pancréatique et CA 19-9. Gastroentérol Clin Biol 9: 204 A.

    Google Scholar 

  50. Zamckeck N, Moore TL, Dhar P, Kupchik H (1972) Immunologic diagnosis and prognosis of human digestive tract cancer. Carcino-embryonic antigens. New Engl J Med 286: 83–86

    Article  Google Scholar 

Download references

Authors
  1. A. Dubois
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chirurgie Digestive, Hôpital Caremeau, Centre hospitalier régional et universitaire de Nîmes, Rue du Prof. Robert-Debré, F-30006, Nîmes, France

    Hughes Baumel  & Bernard Deixonne  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dubois, A. (1986). Biological Examinations. In: Baumel, H., Deixonne, B. (eds) Exocrine Pancreatic Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71178-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71178-7_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71180-0

  • Online ISBN: 978-3-642-71178-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation